Abraxis Oncology

Abraxis Oncology® is the proprietary pharmaceuticals division of Abraxis BioScience, LLC, an integrated global bio-pharmaceutical company. Abraxis Oncology® is dedicated to the discovery and development of novel cancer therapies that target tumor biological pathways. Our focus is to challenge current standards and develop next-generation therapies that revolutionize the treatment of cancer.